AVLSA
Atlas Venture Life Science Advisors’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-90,072
| Closed | -$2.29M | – | 16 |
|
|
2023
Q1 | $2.29M | Hold |
90,072
| – | – | 0.31% | 15 |
|
|
2022
Q4 | $2.63M | Hold |
90,072
| – | – | 0.32% | 15 |
|
|
2022
Q3 | $1.85M | Hold |
90,072
| – | – | 0.2% | 17 |
|
|
2022
Q2 | $1.04M | Hold |
90,072
| – | – | 0.17% | 15 |
|
|
2022
Q1 | $1.67M | Hold |
90,072
| – | – | 0.21% | 16 |
|
|
2021
Q4 | $1.78M | Buy |
+90,072
| New | +$1.78M | 0.16% | 16 |
|